Cargando…

Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer

Nanoscopic therapeutic systems that incorporate therapeutic agents, molecular targeting, and imaging capabilities have gained momentum and exhibited significant therapeutic potential. In this study, multifunctional polymeric nanoparticles with controlled drug delivery, cancer-targeted capability, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Youqiang, Lin, Shaoxiong, Yang, Fei, Situ, Jie, Lin, Shudong, Luo, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201588/ https://www.ncbi.nlm.nih.gov/pubmed/32420382 http://dx.doi.org/10.1155/2020/9186583

Ejemplares similares

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
por: Wu, Xin, et al.
Publicado: (2011)

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
por: Agnello, Lisa, et al.
Publicado: (2021)

Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
por: Dai, Liang, et al.
Publicado: (2021)

Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy
por: Jiang, Wenjun, et al.
Publicado: (2020)

Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer
por: Tng, Danny Jian Hang, et al.
Publicado: (2015)

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai, Zongguang, et al.
Publicado: (2020)

Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
por: Yang, Linlin, et al.
Publicado: (2023)

Carbon Dots-AS1411 Aptamer Nanoconjugate for Ultrasensitive Spectrofluorometric Detection of Cancer Cells
por: Motaghi, Hasan, et al.
Publicado: (2017)

Multifunctional Polymeric Micelles for Cancer Therapy
por: Jin, Geun-Woo, et al.
Publicado: (2022)

Insights into Aptamer–Drug Delivery Systems against Prostate Cancer
por: Wang, Xueni, et al.
Publicado: (2022)

Multifunctional polymeric micelles for delivery of drugs and siRNA
por: Jhaveri, Aditi M., et al.
Publicado: (2014)

Editorial: Multifunctional Polymeric Materials for Drug and Gene Delivery
por: Feng, Yakai, et al.
Publicado: (2022)

Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison
por: Zheng, Haofeng, et al.
Publicado: (2017)

Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica
por: Condappa, Andrew, et al.
Publicado: (2018)

Prostate-specific Membrane Antigen Based Antibody-drug Conjugates for Metastatic Castration-resistance Prostate Cancer
por: Niaz, Muhammad O, et al.
Publicado: (2020)

A replaceable liposomal aptamer for the ultrasensitive and rapid detection of biotin
por: Sung, Tzu-Cheng, et al.
Publicado: (2016)

Zinc Ion-Stabilized Aptamer-Targeted Black Phosphorus Nanosheets for Enhanced Photothermal/Chemotherapy Against Prostate Cancer
por: Gao, Li, et al.
Publicado: (2020)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Recent progress of aptamer‒drug conjugates in cancer therapy
por: He, Jiaxuan, et al.
Publicado: (2023)

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)

Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
por: Lin, Ting-Ting, et al.
Publicado: (2019)

Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems
por: Fortuni, Beatrice, et al.
Publicado: (2019)

Automated Modular Synthesis of Aptamer–Drug Conjugates for Targeted Drug Delivery
por: Wang, RuoWen, et al.
Publicado: (2014)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
por: Qi, Jianjun, et al.
Publicado: (2022)

A rapid and ultrasensitive colorimetric biosensor based on aptamer functionalized Au nanoparticles for detection of saxitoxin
por: Qiang, Le, et al.
Publicado: (2020)

Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
por: Benachour, Hamanou, et al.
Publicado: (2012)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

NIR-triggerable self-assembly multifunctional nanocarriers to enhance the tumor penetration and photothermal therapy efficiency for castration-resistant prostate cancer
por: Li, Shuqiang, et al.
Publicado: (2023)

Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
por: Ma, Qi, et al.
Publicado: (2019)

PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells
por: Jin, Jian, et al.
Publicado: (2014)

Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
por: Li, Yongshu, et al.
Publicado: (2022)

Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer
por: Deng, Guozhen, et al.
Publicado: (2023)

Ultrasensitive antibody-aptamer plasmonic biosensor for malaria biomarker detection in whole blood
por: Minopoli, Antonio, et al.
Publicado: (2020)

Aptamer-based gold nanoparticle aggregates for ultrasensitive amplification-free detection of PSMA
por: Matteoli, Giulia, et al.
Publicado: (2023)

Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_69ahhe000daefe7hn2teflqj6j